+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Endothelin Receptor Antagonist"

South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 128 Pages
From
Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 134 Pages
  • Africa, Middle East
From
Asia Pacific Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Asia Pacific Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 146 Pages
  • Asia Pacific
From
Europe Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Europe Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 148 Pages
  • Europe
From
Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • January 2023
  • 174 Pages
  • Global
From
Japan Pulmonary Arterial Hypertension Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Pulmonary Arterial Hypertension Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • October 2023
  • 170 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 111 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 250 Pages
  • Global
Opsumit - Product Thumbnail Image

Opsumit

  • Report
  • October 2018
  • 19 Pages
  • Global
From
Letairis - Product Thumbnail Image

Letairis

  • Report
  • October 2018
  • 16 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • October 2023
  • 146 Pages
  • Global
From
Endothelin Receptor Antagonist Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Endothelin Receptor Antagonist Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 96 Pages
  • Global
From
Loading Indicator

The Endothelin Receptor Antagonist (ERA) market is a subset of the cardiovascular drug market. ERA drugs are used to treat a variety of cardiovascular conditions, including hypertension, pulmonary arterial hypertension, and congestive heart failure. These drugs work by blocking the action of endothelin, a hormone that can cause constriction of the blood vessels. This helps to reduce blood pressure and improve blood flow. ERA drugs are generally well-tolerated and have few side effects. The ERA market is highly competitive, with several major pharmaceutical companies offering products. These include Amgen, Bayer, Merck, Novartis, and Pfizer. Other companies, such as Actelion, Gilead, and United Therapeutics, also offer ERA drugs. These companies are continually researching and developing new drugs to improve the treatment of cardiovascular conditions. Show Less Read more